Showing results (141-150 of 160) with videos related to
Sort By:
Pageof 16
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 13, 2023
Lazertinib Versus Gefitinib Tyrosine Kinase Inhibitors in Treatment-Naíve Patients With EGFR-Mutated Advanced NSCLC: Analysis of the Asian Subpopulation in LASER301Thanyanan Reungwetwattana, Byoung Chul Cho, Ki Hyeong Lee, et al.Clinical Lung Cancer|September 23, 2022
Asian Thoracic Oncology Research Group (ATORG) Expert Consensus Statement on MET Alterations in NSCLC: Diagnostic and Therapeutic ConsiderationsMyung-Ju Ahn, Marvin Jonne L Mendoza, Nick Pavlakis, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 22, 2023
Central Nervous System Outcomes of Lazertinib Versus Gefitinib in EGFR-Mutated Advanced NSCLC: A LASER301 Subset AnalysisRoss A Soo, Byoung Chul Cho, Joo-Hang Kim, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 28, 2023
Lazertinib Versus Gefitinib as First-Line Treatment in Patients With EGFR-Mutated Advanced Non-Small-Cell Lung Cancer: Results From LASER301Byoung Chul Cho, Myung-Ju Ahn, Jin Hyoung Kang, et al.Science Translational Medicine|December 20, 2013
Structural, biochemical, and clinical characterization of epidermal growth factor receptor (EGFR) exon 20 insertion mutations in lung cancerHiroyuki Yasuda, Eunyoung Park, Cai-Hong Yun, et al.Lung Cancer (Amsterdam, Netherlands)|January 30, 2022
Three-year follow-up and patient-reported outcomes from CheckMate 078: Nivolumab versus docetaxel in a predominantly Chinese patient population with previously treated advanced non-small cell lung cancerJianhua Chang, Yi-Long Wu, Shun Lu, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 28, 2026
Consensus statement on ctDNA minimal residual disease (MRD) testing in early-stage NSCLC - A Delphi study by the Asian Thoracic Oncology Research Group (ATORG)Aaron C Tan, Bin-Chi Liao, Molly Li, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2025
Zipalertinib in Patients With Epidermal Growth Factor Receptor Exon 20 Insertion-Positive Non-Small Cell Lung Cancer Previously Treated With Platinum-Based Chemotherapy With or Without AmivantamabZofia Piotrowska, Antonio Passaro, Danny Nguyen, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 19, 2020
Treatment Guidance for Patients With Lung Cancer During the Coronavirus 2019 PandemicAnne-Marie C Dingemans, Ross A Soo, Abdul Rahman Jazieh, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 1, 2022
Phase Ib/II Dose Expansion Study of Lenvatinib Combined with Letrozole in Postmenopausal Women with Hormone Receptor-Positive Breast CancerJoline S J Lim, Andrea L A Wong, Samuel G W Ow, et al.Pageof 16